FDA Investigator Ann Marie Montemurro

Ann Marie Montemurro has inspections in 12 countries as of 29 Sep 2023. Ann Marie Montemurro has collaborated with a combinined 8914 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
70
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America, Ireland, Denmark, Italy, Switzerland, United Kingdom of Great Britain and Northern Ireland, France, Austria, Germany, Canada, Belgium
Co-Investigator(s):
A Williams, Adetutu M Gidado, Alan L Truong, Albert A Salvador, Alberto A Viciedo, Alice C Silva, Alicia Gilbert, Alicia M Mozzachio, Alla Kachko, PhD, Allen Lou, Alois P Provost, Amy L Singer, Amy M Cramer, Ana S Cabrera, Anastasia G Lolas, Anastasia I Offordile, Anastasia M Shields, Andrea Siegel, PhD, Andrew Chang, Andria L Kuhlman, Angela Jourdain, Angela R Jourdain, Anissa M Cheung, Anita Narula, PhD, Anita R Michael, Ann L Demarco, Ann Marie Schofield, Anna Marie Schofield, Anne E Johnson, Annemarie Bodnar, Annette A Ragosta, Anthony F Lorenzo, Arduino Frankovic, Arie C Menachem, Arthur S Williams, Jr, Ashley J Burns, Atul J Agrawal, Audrey Thereset Uy, Barbara Janine Breithaupt, Barbara Jwilimczyk Macri, Barbara L Rellahan, PhD, Barry Cherney, PhD, Ben Du, Bo Chi, PhD, Brandon C Heitmeier, Brandy N Lepage, Brentley S Collins, Brian D Nicholson, Brian S Keefer, Bruce D Meade, Bruce H Mccullough, Burnell M Henry, Byungja E Marciante, Calvin B Koerner, Cara M Minelli, Carl A Anderson, Carl Lee, Carla A Norris, Carla J Lundi, Carol L Rehkopf, Carolyn A Renshaw, Carolyn Yong, PhD, Carrie Ann Plucinski, Caryn M Mcnab, Cassandra Overking, CDR Donald Ertel, CDR Jeremy L Wally, PhD, Chad R Burger, Chao Ming Tsai, Charles I Ann, Charles M Edwards, Chiang Syin, PhD, Christian D Lynch (CDL), Christina A Miller, Christina D Lynch, Christina H Owens, Christina J Sauder, PhD, Christina K Theodorou, Christina Theodorou, Christina V Santos, Christine A Harman, PhD, Christopher J Adams, Christopher R Czajka, Claire M Minden, Craig D Zagata, Creighton T Tuzon, Cynthia Jim, CSO, Cynthia L Kelley, Cynthia White, Daniel J Grabicki, Daniel Lagasse, Daniel T Lee, Dave Hafner, David E Bailey, David J Hafner, David J Hapner, David K Lau, David M Beltran, David Perkins, Dawn L Wydner, Deborah B Nixon, Deborah M Trout, Debra I Love, Debra J Bennett, Debra L Pagano, Dennis Cantellops Paite, Derek C Price, Destry M Sillivan, Dinesh Kumar, Dino Feigelstock (DF), PhD, Donald C Obenhuber, PhD, Dongping Dai, PhD, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Gang Wang, PhD, Dr. Guang Gao, PhD, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. Willie F Vann, PhD, Dr. Zhou Chen (nmi), MD PhD, Edmund F Mrak, Jr, Edmund Fmrakjr S, Edward Patten, Eileen A Liu, Eliezar Ramos, Ellen Huang, Ellen P Madigan, Elmina E Akwo, Emmanuel J Ramos, Eric J Cunningham, Eric Rothschild, Erika M Wilkerson, Erika V Butler, Erin D Mccaffery, Eural E Porter, Frank J Marciniak, Frank Wackes, Freddy Ortiz Colon, Frederick Razzaghi, Fulton A Varner, Gabrielle J Swain, Gayle S Lawson, Gene D Arcy, George Pyramides, Gerald B Seaborn, Jr, Gianine E Tompkins, Ginger M Sykes, Grace E Mcnally, Guerlain Ulysse, Gunther Boekhoudt, PhD, Gwyn G Dickinson, Haitao Li, Hala L Selby, Haruhiko Murata, Helen B Ricalde, Helen R Bester, Helen Verdel, Holly Brevig, Humera Khan, Hyesuk Kong, Ivis Lnegron Torres, J David Doleski, Jacqueline Mdiaz Albertini, James C Lee, PharmD, James C Maclaughlin, James E Keller, PhD, James L Dunnie, Jr, James L Kenney, DSc, James M Mason, James M Simpson, James P Mcevoy, James R Evans, James T Mccoy, Janet L Bowen, Jason F Chancey, Jawaid Hamid, Jean Lhu Primmer, Jean M Kelahan, Jeanne M Morris, Jeffrey M Watson, Jennifer L Bridgewater, Jennifer L Schmidt, Jennifer Macmillan, Jessica L Pressley, Jianming Li, Jie He, Joan A Loreng, Joan Adamo, Joan Johnson, Joanne E King, Joanne M Hajoway, Joanne Pryzbylik, Jocelyn C Turner, Jogy George, John M Mcinnis, John S Hartford, John Stansberry, PhD, Jonathan G Matrisciano, Jonee J Mearns, Jose A Cruz, Jose Acruz Gonzalez, Jose M Cayuela, Joseph F Mcginnis, RPh, Joseph George, Joseph L Despins, PhD, Joseph R Lambert, Joy Rkozlowski Klena, Jude C Dikes, Julia D Bringger, Julianne C Mccullough, Julie D Bringger, Junho Pak, Justin A Boyd, Justine Tomasso, Kalavati Suvarna, PhD, Karen A Coleman, Karen E D'orazio, Karyn M Campbell, Katherine E Jacobitz, Kathleen B Mihalik, Kathryn Carbone, MD, Kelli F Dobilas, Kelly I Anderson, Kelly N Kerr, Kelvin Cheung, Kendra L Brooks, Kenneth M Gordon, Kent C Faul, Kevin D Kallander, Kevin M Maguire, Kevin P Foley, Kim Lthomas Cruse, Kimberley A Hoefen, Kimberly M Bigler, Kinh Q Mac, Kristen D Evans, Kristina J Donohue, Kristina Mjoyce Pittman, Kristy A Zielny, Kurt A Brorson, PhD, Lakshmi Narasimhan, PhD, Larry K Austin, Laura Fontan, MS, Laurel A Beer, Lauren L Vajo, Laurie B Frazier, Laurie P Norwood, LCDR Debra Emerson, LCDR Margaret E Digennaro, LCDR Susan E Polifko, Lequita M Mayhew, Leslie D Wagner, Li Li, Liatte Kreuger, PharmD, Linda Thai, Lindan E Silvers, Lindsey R Lyman, Lisa Feela, Lisa M Bellows, Lisa M Feola, Lisa P Oakes, Lisa Pierce Oakes, Lixia Cai, Lorelei S Jarrell, Loretta Nemchik, Lori S Lawless, LT John M Mastalski, LTJG Bradley E Benasutti, Lu Deng, Lydia Irosas Marty, Madushini Dharmasena, PhD, Maotang Xhou, Maotang Zhou, PhD, Marc S Neubauer, Marcelo O Mangalindan, Jr, Marcus F Yambot, Margaret M Annes, Maria Estrella, Marian E Major, PhD, Marie Bbuen Bigornia, Marie F Morin, Marion Michaelis, Mariza M Jafary, Mark R Mcclain, Marla A Cassidy, Marlene G Swider, Marsha W Major, Marsha W Nasur, Martha O'lone, Martha Sullivan Myrick, Martha T Olone, Mary Alice Papdimitriou, Mary P Padgett, Mary T Carden, Maryna C Eichelberger, PhD, Matthew A Spataro, Maxwell Van Tassell, PhD, Megan A Haggerty, Meihong Liu, Melba T Rivera, Melba Trivera Clavell, Melissa D Ray, Melissa T Roy, Michael A Charles, Michael Curbag, Michael D Omeara, Michael Gurbarg, Michael R Goga, Michael R Klapal, Michael Schmitt, Michael Serrano, Michael Shanks, MS, Michele L Forster, PhD, Michele Perry Williams, Mihaly S Ligmond, Mike M Rashti, Mikhail V Ovanesov, PhD, Mindy M Chou, Minh D Phan, Mizanne E Lewis, Morris Paul, Morris Sheldon, PhD, Mra Davism, Mra M Barbosar, Mra Mcculloughj, Murthy Vkn Sikha, Myra K Casey, Nancy E Kirschbaum, Nancy F Scheraga, Nancy G Schmidt, Nancy L Neiger, Nancy L Rolli, Nancy T Waites, Nawab A Siddiqui, Nerizza B Guerin, Nicholas A Violand, Nicholas F Lyons, Nicholas P Diorio, Nicole J Clausen, Nicole K Trudel, Niketa Patel, Nikisha M Bolden, Nimmy Mathews, Niraj Mehta, Noreen Muniz, Omotunde O Osunsanmi, Pankaj H Amin, Parul M Patel, Patricia A Morrow, Patricia F Hudson, Patricia Fhughes Troost, Patrick C Klotzbuecher, Patsy J Domingo, Paul A Bonneau, Paul E Stein, Paul L Bellamy, Paul W Moy, Paul Z Balcer, Paula A Trost, Peter R Lenahan, Philip F Istafanos, DMV, MS, Phillip M Pontikos, Phung Thien Nguyen, Prabhu P Raju, Priscilla M Pastrana, Qiao Y Bobo, Rajiv R Srivastava, Ralph A Erickson, Ralph Jerndal, Ramesh Potla, PhD, Ramjay Vatsan, PhD, Ramon E Martinez, Randa Melhem, PhD, Rebecca K Olin, Rebecca Rodriguez, Regina Gibson Melton, Regina T Brown, Reginald D Neal, Reyes Candau Chacon, PhD, Richard D Manney, Richard H Penta, Richard Jay Tucker, RS, Richard K Vogel, Richard W Thornton, Richard W Thorntton, Robert B Shibuya, MD, Robert C Coleman, Robert D Tollefsen, Robert J Maffei, Robert J Martin, Robert L Stevenson, Robert Sausville, Robert W Jennings, Robin P Mathew, Rochelle K Kimmel, Rodney D Combs, Roger F Zabinski, Roman Drews, PhD, Roman T Drews, PhD, Rona A Leblanc, Rona Leblanc, PhD, Ronald T Nowalk, Rory K Geyer, Rose Ashley, Rose M Ashley, Rumany C Penn, PharmD, Russ R Rivy, Russell J Glapion, Russell K Riley, Samantha J Bradley, Samuel K Gibbons, Jr, Sandra Kershaw, Sarah Adella Fave, Sarah B Tanksley, Sarah Forney, Scott E Norris, Scott T Ballard, Sean R Bryd, Sean R Marcsisin, Sharon K Thoma, PharmD, Sheila Dreher Lesnick, Sheldon Morris, Shelley L Waring, Sherry G Bous, Sheryl A Kochman, Shirley H Isbill, Shuang Tang, Shwnji Susie Lee, Sidney B Priesmeyer, Simone E Pitts, Sinai Davis, Solomon Yimam (SY), Stephanie A Slater, MS, Stephanie Mangigian, MS/OSH, RN, Stephen C Smith, Stephen D Brown, Stephen D Eich, Steven A Gonzales, Steven A Rubin, Steven C Derrick, Steven C Madzo, Steven E Bowen, PhD, Steven L Carter, Steven M Weinman, Steven P Donald, Subramanian Muthukkumar, PhD, Susan A Zullo, PhD, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Susan Yu, Susant Hadman, Tamil Arasu, PhD, Tammy L Chavis, Tania E Vizcaino, Temar Q Williams, Teresita C Mercado, Terrig Thomas, PhD, Thai D Truong, Thomas E Friel, Thomas J Arista, Thomas R Withers, Thunder N Dunkijacobs, Thuy T Nguyen, LCDR, Tina S Roecklein, Todd J Maushart, Todd M Stankewicz, Troy C Quander, Unnee Ranjan, Verlinda A Narcisse, Vijaya L Simhadri, Virgilio F Pacio, CSO, Viviana Matta, Vlada Matusovsky, Warren J Lopicka, Wayne E Seifert, Wayne J Meyer, Wayne T Smith, Wei Wang, PhD, William D Tingley, Willie Wilson, Xiao Wang, Xiaokuang Lai, PhD, Yangmin Ning, Yanming An, PhD, Yasamin Ameri, Yehualashet A Gessesse, Yonggang Wang, PhD, Yumi J Hiramine, Zachary L Miller, Zachary L Stamm, Zakaria I Ganiyu, Zhihao Qiu (Peter), PhD, Zhijin Chen, Zhong Li, PhD, Zuben E Sauna, PhD

Ann Marie Montemurro's Documents

Publish Date Document Type Title
November, 2006 EIR Janssen Biotech, Inc. - EIR, 2006-11-30
December, 2000 FDA 483 Bayer HealthCare LLC - Form 483, 2000-12-07
May, 2002 EIR Merck Sharp & Dohme LLC - EIR, 2002-05-03
October, 2008 FDA 483 Lonza Walkersville, Inc. - Form 483, 2008-10-10
October, 2000 EIR Merck Sharp & Dohme LLC - EIR, 2000-10-11
February, 2004 FDA 483 Response Janssen Biotech, Inc. - Form 483R, 2004-03-10
May, 2001 EIR Fareva Pau - EIR, 2001-06-06
August, 2002 FDA 483 AbbVie Inc. - Form 483, 2002-08-15
May, 2002 FDA 483 Response Merck Sharp & Dohme LLC - Form 483R, 2002-05-20
February, 2000 EIR MSD International GmbH - EIR, 2000-07-26
February, 2000 EIR Corixa Corporation - EIR, 2000-02-17
December, 2005 FDA 483 Ortho Clinical Diagnostics - Form 483, 2005-12-09
December, 2009 FDA 483 AstraZeneca Pharmaceuticals LP - Form 483, 2009-12-07
October, 2001 EIR Antigen Laboratories-Columbus - EIR, 2001-10-12
December, 2002 FDA 483 Response EUSA Pharma (USA) Inc. - Form 483R, 2003-01-17
January, 2008 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2008-01-17
May, 2001 EIR Baxalta Belgium Manufacturing SA - EIR, 2001-05-02
December, 2002 EIR EUSA Pharma (USA) Inc. - EIR, 2002-12-20
April, 2006 FDA 483 Sanofi Pasteur Inc. - Form 483, 2006-04-28
February, 2004 FDA 483 Janssen Biotech, Inc. - Form 483, 2004-02-11
August, 2002 FDA 483 Response AbbVie Inc. - Form 483R, 2002-08-28
July, 2001 FDA 483 Ortho-Clinical Diagnostics, Inc. - Form 483, 2001-07-27
August, 2004 FDA 483 Response Amgen, Inc. - Form 483R, 2004-08-27
February, 2000 FDA 483 Corixa Corporation - Form 483, 2000-02-17
January, 2005 FDA 483 Hoffmann La Roche Inc - Form 483, 2005-01-25
May, 2008 FDA 483 ID Biomedical - Form 483, 2008-05-22
January, 2005 EIR Hoffmann La Roche Inc - EIR, 2005-01-25
December, 2002 FDA 483 Cytogen Corporation - Form 483, 2002-12-20
March, 2002 FDA 483 Novo Nordisk A/S - Hax - Form 483, 2002-03-07
March, 2001 EIR Vericel Corporation - EIR, 2001-03-29
January, 2005 FDA 483 Response Hoffmann La Roche Inc - Form 483R, 2005-02-09
June, 2001 FDA 483 AIM ImmunoTech Inc - Form 483, 2001-06-28
June, 2003 EIR Patheon Biologics (NJ) LLC - EIR, 2003-06-04
May, 2001 FDA 483 Response Baxalta Belgium Manufacturing SA - Form 483R, 2001-05-11
June, 2003 FDA 483 Patheon Biologics (NJ) LLC - Form 483, 2003-06-04
February, 2000 FDA 483 Response Corixa Corporation - Form 483R, 2000-05-03
October, 2000 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2000-10-11
August, 2000 FDA 483 Response DPT Lakewood, Inc. - Form 483R, 2000-09-01
April, 2004 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2004-04-22
October, 2001 FDA 483 Antigen Laboratories-Columbus - Form 483, 2001-10-12
October, 2002 EIR Johnson & Johnson Pharmaceutical Research & Development, LLC - EIR, 2002-10-28
September, 2002 FDA 483 Emergent Biodefense Operations Lansing LLC - Form 483, 2002-09-13
November, 2006 FDA 483 Response Janssen Biotech, Inc. - Form 483R, 2007-05-29
May, 2002 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2002-05-03
August, 2002 EIR AbbVie Inc. - EIR, 2002-08-15
September, 2002 FDA 483 Response Emergent Biodefense Operations Lansing LLC - Form 483R, 2002-10-07
August, 2000 FDA 483 DPT Lakewood, Inc. - Form 483, 2000-08-11
January, 2003 FDA 483 Immunomedics, Inc. - Form 483, 2003-01-23
June, 2003 FDA 483 Response Patheon Biologics (NJ) LLC - Form 483R, 2003-06-19
June, 2002 FDA 483 Merck Teknika LLC - Form 483, 2002-06-07
December, 2005 EIR Ortho Clinical Diagnostics - EIR, 2005-12-09
August, 2001 EIR Ortho Clinical Diagnostics - EIR, 2001-08-31
March, 2000 FDA 483 Response Allergan Pharmaceuticals Ireland - Form 483R, 2000-03-29
December, 2000 EIR Bayer HealthCare LLC - EIR, 2000-12-07
July, 2001 EIR Ortho-Clinical Diagnostics, Inc. - EIR, 2001-07-27
November, 2006 FDA 483 Janssen Biotech, Inc. - Form 483, 2006-11-30
February, 2000 FDA 483 MSD International GmbH - Form 483, 2000-02-29
June, 2002 EIR Merck Teknika LLC - EIR, 2002-06-07
October, 2002 FDA 483 Response Johnson & Johnson Pharmaceutical Research & Development, LLC - Form 483R, 2002-11-11
February, 2004 EIR Janssen Biotech, Inc. - EIR, 2004-02-11
October, 2002 FDA 483 Johnson & Johnson Pharmaceutical Research & Development, LLC - Form 483, 2002-10-28

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more